Μ-opioid receptor

From WikiMD's WELLNESSPEDIA

(Redirected from Mu-opioid receptor)

Μ-opioid receptor (MOR) is a type of opioid receptor with high affinity for enkephalins and beta-endorphin but low affinity for dynorphins. It is considered the principal receptor target of the opioid drug morphine.

Structure[edit]

The Μ-opioid receptor is a G protein-coupled receptor (GPCR) that responds to the endogenous opioid peptides endorphin, enkephalin, and dynorphin. It is encoded by the OPRM1 gene. The receptor is a 400-amino acid polypeptide, with a molecular weight of approximately 50,000 daltons.

Function[edit]

The Μ-opioid receptor is involved in a variety of physiological functions, including pain perception, mood regulation, immune response, and gastrointestinal motility. Activation of the receptor by an agonist leads to inhibition of adenylate cyclase, decreased production of cAMP, and reduced neuronal excitability.

Pharmacology[edit]

The Μ-opioid receptor is the primary target of most opioid drugs, including morphine, heroin, and fentanyl. These drugs mimic the action of endogenous opioids to produce analgesia and euphoria. However, chronic use of these drugs can lead to tolerance and dependence.

Clinical significance[edit]

Alterations in Μ-opioid receptor function have been implicated in a variety of disorders, including chronic pain, addiction, and mood disorders. In addition, genetic variations in the OPRM1 gene have been associated with differences in pain perception and response to opioid drugs.


This GPCR-related article is a stub. You can help WikiMD by expanding it.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.